Gedea Biotech receives funding from Vinnova

Vinnova has granted Gedea Biotech's application for innovative startup companies. The applications were reviewed by external assessors and Gedea Biotech was one of the selected among over 650 applicants. Gedea Biotech develops a novel treatment of vaginal candida infections. In the project a prototype of the vaginal tablet will be formulated.
Read more
kartaGedea Biotech AB
Medicon Village
Scheeletorget 1
223 81 Lund
Sweden
Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 - 91 86 81

Privacy Policy | Cookie Policy